HomeAI-TechRIVANNA Wins FDA...

RIVANNA Wins FDA Clearance for BoneEnhance AI Module on Accuro XV – Unite.AI


RIVANNA introduced on October 22, 2026, that the U.S. Meals and Drug Administration granted 510(okay) clearance for BoneEnhance, a machine studying software program module for the corporate’s Accuro XV diagnostic ultrasound system. The module segments bone and surrounding tissues and helps visualization of skeletal anatomy in three dimensions throughout picture assessment.

The Charlottesville, Virginia-based firm, which develops AI-enabled medical decision-support techniques, described BoneEnhance as the primary machine studying software program module cleared for the Accuro XV platform. RIVANNA framed the clearance as transferring the platform from acquisition towards interpretation: the Accuro XV performs the volumetric picture acquisition, and BoneEnhance labels the anatomy captured inside it. The underlying system was cleared in April 2026 for B-mode imaging in musculoskeletal standard and superficial purposes, in line with the discharge; RIVANNA publicly introduced that earlier clearance on Might 7, 2026.

How BoneEnhance Works on the Accuro XV

Every automated Accuro XV acquisition produces a volumetric dataset for assessment. Inside that quantity, BoneEnhance identifies bone and surrounding tissues, then marks them with color-coded overlays on the two-dimensional B-mode picture. The overlays go away the unique anatomical information unchanged and visual beneath, and an on-screen three-dimensional indicator reveals the scan’s orientation and the place the displayed slice sits throughout the acquired quantity.

Co-founder and CEO Will Mauldin stated RIVANNA was based to handle an issue that cuts throughout care settings: decision-critical data sitting outdoors the point-of-care workflow. “BoneEnhance is the place the stack begins to shut that hole for musculoskeletal care: automated volumetric acquisition, now paired with cleared software-assisted assessment,” Mauldin stated, calling the clearance the inspiration for decision-support capabilities now in improvement.

The cart-based Accuro XV makes use of a conformable three-dimensional probe with motorized linear translation to accumulate B-mode photographs throughout a 10-centimeter scan extent, automating giant field-of-view acquisition after preliminary affected person positioning. A compliant polyurethane stand-off medium varieties a affected person contact floor that conforms to irregular anatomies to enhance acoustic coupling. The system features a touchscreen interface, an built-in battery pack for point-of-care mobility, and DICOM-compatible picture archival workflows.

The system’s earlier clearance, introduced on Might 7, 2026, licensed industrial use of the Accuro XV for musculoskeletal imaging by certified and skilled healthcare professionals in hospital and medical clinic environments. RIVANNA says the built-in workflow is backed by a worldwide intellectual-property portfolio of greater than 100 issued and pending patents throughout greater than 20 patent households.

Validation Throughout Eight Websites

BoneEnhance was skilled and validated inside RIVANNA’s nationwide eight-site medical examine. Three websites contributed the coaching information, and the opposite 5 supplied an impartial check set of 233 volumetric datasets comprising 69,900 photographs from 173 topics. In keeping with the discharge, not one of the check information had been used for coaching or tuning. Three board-certified radiologists established the reference labels, and RIVANNA reported that per-volume label prediction accuracy, a measure of anatomical labeling, ranged from 95.1% to 100.0%.

Separate from the validation supporting the BoneEnhance clearance, the corporate cited peer-reviewed proof for the platform’s automated acquisition. In a examine of 205 sufferers revealed within the Journal of Emergency Drugs, operators with one hour of hands-on coaching acquired wrist and ankle photographs rated satisfactory for diagnostic interpretation in additional than 90% of scans, with picture high quality akin to physician-acquired scans. RIVANNA’s earlier clearance announcement states that the examine was carried out at UVA Well being and UT Southwestern Medical Middle and that it in contrast non-physician operators with board-certified emergency physicians.

Research Progress and the Harm Detection Module

The medical examine behind BoneEnhance has continued to develop. RIVANNA introduced in April 2026 that the examine had expanded from two websites to eight — Denver Well being, Texas Tech Well being El Paso, the College of California, San Francisco, the College of Utah, UVA Well being, UT Southwestern Medical Middle, Virginia Commonwealth College, and Yale College — after the Biomedical Superior Analysis and Improvement Authority (BARDA) executed a funding possibility. At that stage, this system was coaching CADe/x, which RIVANNA describes as the primary computer-aided detection algorithm for automated fracture identification derived from volumetric ultrasound imaging, and finishing validation of BoneEnhance.

In keeping with the brand new launch, the examine has since expanded from eight to 10 websites and is constructing the datasets used to coach an investigational musculoskeletal damage detection module for the Accuro XV. The place BoneEnhance labels anatomy, the investigational module is being developed to help clinicians in evaluating potential extremity fractures inside acquired ultrasound photographs. The discharge states that as a result of the websites and information infrastructure had been established as soon as and are reused for every new module, each subsequent module builds on this system’s federal funding.

Delphine Le Roux, RIVANNA’s senior director of market entry and strategic partnerships, credited the taking part medical websites and BARDA’s sustained help for the proof program behind the clearance. “The infrastructure, partnerships, and regulatory playbook we established for BoneEnhance are designed to hold ahead,” she stated.

The challenge has been supported in entire or partly with federal funds from the U.S. Division of Well being and Human Providers, the Administration for Strategic Preparedness and Response, and BARDA, below contract quantity 75A50121C00035.



Supply hyperlink

Get notified whenever we post something new!

spot_img

Continue reading

Africa’s Trade Deficit With China Tops $100 Billion

Africa’s trade deficit with China hit $101.4 billion in the first 10 months of 2026, representing a 27.73% increase from the corresponding period last year. Total bilateral trade reached a record $346.8 billion, with Chinese exports to Africa rising...

AfDB Bets on Homegrown Capital to Fund Growth

The African Development Bank is advancing a new financing strategy aimed at reducing Africa’s dependence on external development assistance by mobilizing more domestic capital. The shift comes amid declining foreign aid, rising debt pressures, and growing development needs. The...

Zimbabwe Moves to Strengthen ZiG

Zimbabwe is moving to strengthen its gold-backed ZiG currency by developing a domestic bond market and extending the maturity of local-currency financial instruments. Central bank Governor John Mushayavanhu said the authorities want the ZiG to function as a store...

advert